100000 Participants Needed

Clinical Care Improvement for Epilepsy

(ELHS Trial)

Recruiting at 13 trial locations
KF
BE
Overseen ByBrandy E Fureman, PhD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Epilepsy Foundation of America
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial focuses on improving care and outcomes for people with epilepsy through a network of healthcare professionals, patients, and researchers. It aims to enhance epilepsy treatment by collecting data during regular care to develop better care strategies. The trial will test various methods across several hospitals to determine the most effective approaches. Individuals with epilepsy who are currently receiving care at one of the participating centers might be suitable candidates for this trial. As an unphased trial, it offers a unique opportunity to contribute to innovative strategies that could enhance epilepsy care for many.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this clinical care and quality improvement is safe for epilepsy patients?

Research has shown that the methods used in the Epilepsy Learning Health System (ELHS) lead to positive results and are generally well-received. For instance, one study found that following a standardized care plan reduced hospital readmissions by 27.6% for children with epilepsy. This suggests that the methods in this trial can be safe and effective.

The ELHS aims to improve epilepsy care by using data and consistent practices. Although specific information on side effects is not available, the methods do not involve new medications or invasive procedures, suggesting a low risk of negative side effects. Participants in similar programs have reported a better quality of life, indicating that the treatment is not only safe but also beneficial.12345

Why are researchers excited about this trial?

Researchers are excited about the Epilepsy Learning Healthcare System (ELHS) trial because it aims to revolutionize epilepsy care through a new approach. Unlike traditional treatments that focus solely on medication, ELHS is about changing how epilepsy care is delivered across various centers. By using Quality Improvement methods in a Chronic Care model, this trial introduces standardized epilepsy care metrics and rapid feedback loops. This network-based approach has never been applied to epilepsy before and could significantly improve clinical outcomes by ensuring that care is consistent, data-driven, and continuously improved based on real-world evidence.

What evidence suggests that this clinical care and quality improvement method is effective for epilepsy?

Research has shown that improving care for people with epilepsy can lead to better health outcomes. In this trial, centers participating in the Epilepsy Learning Health System (ELHS) aim to enhance health results by implementing changes through Quality Improvement methodology. One study found that gathering patient feedback and using quality checks can identify ways to improve epilepsy care. Evidence suggests that using standard care guidelines and receiving feedback can help manage epilepsy more effectively. These approaches focus on reducing seizures and improving the overall health and quality of life for those affected.12346

Who Is on the Research Team?

BF

Brandy Fureman, PhD

Principal Investigator

Epilepsy Foundation

Are You a Good Fit for This Trial?

Inclusion Criteria

I am currently receiving care from the ELHS site.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Data Collection and Quality Improvement

Participants' clinical data are collected and analyzed to improve epilepsy care through quality improvement methods such as Plan-Do-Study-Act (PDSA) cycles.

Ongoing

Follow-up

Participants are monitored for seizure control and quality of life improvements, with data reviewed monthly to assess outcomes.

12 months

What Are the Treatments Tested in This Trial?

Interventions

  • Clinical care and quality improvement

How Is the Trial Designed?

12

Treatment groups

Experimental Treatment

Group I: University of Southern California (USC)Experimental Treatment1 Intervention
Group II: University of Colorado AnshutzExperimental Treatment1 Intervention
Group III: University of Cincinnati Gardner Neuroscience InstituteExperimental Treatment1 Intervention
Group IV: UT Southwestern Children's DallasExperimental Treatment1 Intervention
Group V: Penn State HersheyExperimental Treatment1 Intervention
Group VI: Mass General HospitalExperimental Treatment1 Intervention
Group VII: Cincinnati Children's Hospital Medical CenterExperimental Treatment1 Intervention
Group VIII: Children's Hospital of Philadelphia (CHOP)Experimental Treatment1 Intervention
Group IX: Children's Hospital of Orange County (CHOC)Experimental Treatment1 Intervention
Group X: Children's Hospital Los AngelesExperimental Treatment1 Intervention
Group XI: Brigham & Women's HospitalExperimental Treatment1 Intervention
Group XII: Barrow Neurological Institute Comprehensive Epilepsy CenterExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Epilepsy Foundation of America

Lead Sponsor

Trials
2
Recruited
100,000+

Citations

Implementation of quality measures and patient-reported ...

In this study, we identified several opportunities for quality improvement in epilepsy care through collection of patient reports on care quality and PRO. Real- ...

Epilepsy Learning Healthcare System (ELHS)

The Epilepsy Learning Health System (ELHS) is a quality improvement and research network to improve outcomes for people with epilepsy.

Quality improvement in neurology

People with epilepsy can have poor overall health status, impaired intellectual and physical functioning, elevated risk of accidents and injuries, and negative ...

Establishing a Learning Healthcare System to Improve ...

Objective: To describe the organization of the Epilepsy Learning Healthcare System (ELHS), a network that aims to improve care outcomes for people with ...

Establishing essential clinical data elements for efficient ...

Epilepsy requires consistent management to improve patient outcomes, minimize its impact on the quality of life, and reduce seizure risk [1,2]. However, ...

Seize the day: A quality improvement approach to support ...

A 27.6% reduction in 30-day readmission of children with epilepsy was achieved through use of a standardized pathway. Abstract. Purpose. Elevated rates of 30- ...